Post-Registration Changes: Twelve Types

1. Key takeaways

After a registration certificate has been issued, any change that differs from the conditions recorded at the time of issuance must be processed as a post-registration modification. Article 52 of Acuerdo No. 0631-ARSA-2023 breaks these changes into twelve categories (a–l): change of the registered company name, shelf life (validity period), storage conditions, change or addition of distributors, product specifications, legal representative, expansion of commercial packaging sizes, chemical composition, discontinuation of approved specifications, product owner, manufacturer and country of origin, and the registered company itself. The general documentation consists of the application form (containing all twelve data points a–l), a sworn declaration, and the type-specific documents appended according to the category, plus proof of payment of the fee (item 4). Three boundary provisions are equally important: Article 49 provides that a modification retains the original registration number and the original validity period; Article 50 provides that a registration that has already expired is no longer granted a modification, and is instead handled as a renewal under the Reglamento de Vigilancia y Fiscalización Sanitaria; and Article 51 provides that modifications are the exclusive competence of ARSA, and that a registration found to have been changed without authorisation will be declared suspended and cancelled.

2. Legal basis

The table below consolidates the provisions cited for post-registration modifications in Acuerdo No. 0631-ARSA-2023, together with the key point of each provision.

3. Expert insights

Insight 1: who signs the documents depends on whether the change touches a right or an identity. Under item 3 of Article 52, six categories — b) shelf life, c) storage conditions, e) specifications, h) chemical composition, j) product owner and k) manufacturer and country of origin — must be supported by a declaration issued by the product owner (titular) and processed through apostillado o autenticado. By contrast, five categories — d) distributors, f) legal representative, g) packaging sizes, i) discontinuation and l) registered company — may be covered by a written declaration from the legal representative of the registered company on letterhead paper. This dividing line determines how many cross-border authentications each modification will require.

Insight 2: only a change of specifications is expressly required to submit scientific evidence. Item e) expressly demands the scientific information supporting the change; the other categories require only declarations and labelling. This means that a change of specifications is in substance a second technical review, whereas changing a distributor or a legal representative is essentially an administrative registration step.

Insight 3: a change of chemical composition requires five documents. Beyond the product owner’s declaration, item h) requires that the technical sheet, the safety sheet, the insert and the IFU all reflect the change simultaneously. This interacts with the composition and concentration statements among the eighteen primary-label items of Article 84, Section 1: changing the formula means changing the entire document set.

Insight 4: every category of change ends with a label update. Except for i) discontinuation, categories b), c), d), e), g), j) and k) all require submission of primary or secondary packaging labels reflecting the change (category d) requires supplementary labels). This closes the loop with Article 84, Section 2, under which supplementary labels must state the ARSA authorisation number: packaging on sale after the modification must visibly show the change.

Insight 5: the modification window is bounded by the validity of the registration. Article 49 makes clear that a modification does not extend the validity period, and Article 50 denies modifications to expired registrations. Combined with the five-year validity and the renewal window opening five months in advance under Article 35, a company that remembers a modification only shortly before expiry may first have to deal with renewal.

Insight 6: the consequence of unauthorised modification is suspension plus cancellation. Article 51 reserves the power to modify exclusively to ARSA (exercised through the medical devices directorate) and provides that once an unauthorised change to a registration is detected, the registration is declared suspended and enters a cancellation procedure. This closes off any strategy of changing first and reporting afterwards.

4. Practical recommendations

• Classify before preparing documents: map the intended change to one of the twelve categories a–l, confirm whether the issuing party is the product owner or the legal representative of the registered company, and avoid running the authentication chain in the wrong direction.
• Authenticate foreign documents early: declarations issued abroad by the product owner for categories b), c), e), h), j) and k) must always be apostillado (Hague member states) or autenticado (non-member states), with a Spanish translation attached.
• Prepare a change of specifications as a second review: assemble in advance the scientific literature, verification reports and risk management updates supporting the change, rather than submitting a bare declaration.
• Synchronise the full document set for formula changes: technical sheet, safety sheet, insert, IFU and labels should be updated in one pass to avoid version conflicts between documents.
• Build modifications into the registration life cycle: complete the modification application at least five months before expiry, or renew first and modify afterwards (Articles 49 and 50).
• Do not alter packaging on sale or publish new product claims before the modification is approved — under Article 51, unauthorised changes are met with suspension and cancellation.

5. Verification checklist

• □ The intended change has been mapped to one of categories a–l and the category code recorded
• □ The issuing party has been confirmed (product owner or legal representative of the registered company)
• □ Apostillado or autenticado for foreign documents and the Spanish translations are ready
• □ Scientific support for a change of specifications has been assembled (item e))
• □ Label artwork reflecting the change (primary, secondary or supplementary) has been laid out
• □ Registration validity and the timing of the modification application have been checked, and the expired-registration situation of Article 50 avoided
• □ Proof of payment for the modification application has been prepared for submission with the dossier

Related reading: [Article 42 — Reclassification and referral to DNPF](/honduras-medical-device-registration/reclassification-and-referral-to-dnpf/) | [Article 45 — Tecnovigilancia rules and the 72-hour clock](/honduras-medical-device-registration/tecnovigilancia-acuerdo-0185-2025/) | [Article 25 — Twelve renewal dossier items](/honduras-medical-device-registration/renewal-dossier-twelve-items/)

Regulatory information verified as of October 29, 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Honduran market. Our team manages Secretariat of Health (SESAL) registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com